0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Dengue Fever Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-12J13245
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Dengue Fever Treatment Market Research Report 2023
BUY CHAPTERS

Dengue Fever Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12J13245
Report
October 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dengue Fever Treatment - Market Size

The global market for Dengue Fever Treatment was estimated to be worth US$ 137 million in 2023 and is forecast to a readjusted size of US$ 155.6 million by 2030 with a CAGR of 0.5% during the forecast period 2024-2030

Dengue Fever Treatment - Market

Dengue Fever Treatment - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dengue Fever Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Dengue Fever Treatment by region & country, by Type, and by Application.
The Dengue Fever Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Fever Treatment.
Market Segmentation

Scope of Dengue Fever Treatment - Market Report

Report Metric Details
Report Name Dengue Fever Treatment - Market
Forecasted market size in 2030 US$ 155.6 million
CAGR 0.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Drug
  • Vaccines
Segment by Application
  • Hospital
  • Homecare
  • Specialty Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fresenius Kabi USA, Sun Pharmaceutical Industries, Mylan N.V, Pfizer, Teva Pharmaceuticals USA, EMERGEX VACCINES, Hikma Pharmaceuticals, ABIVAX, Aurobindo Pharma, Baxter, Perrigo, GlaxoSmithKline, Dr. Reddy’s Laboratories, Sanofi, Takeda Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Dengue Fever Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Dengue Fever Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Dengue Fever Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Dengue Fever Treatment - Market size in 2030?

Ans: The Dengue Fever Treatment - Market size in 2030 will be US$ 155.6 million.

Who are the main players in the Dengue Fever Treatment - Market report?

Ans: The main players in the Dengue Fever Treatment - Market are Fresenius Kabi USA, Sun Pharmaceutical Industries, Mylan N.V, Pfizer, Teva Pharmaceuticals USA, EMERGEX VACCINES, Hikma Pharmaceuticals, ABIVAX, Aurobindo Pharma, Baxter, Perrigo, GlaxoSmithKline, Dr. Reddy’s Laboratories, Sanofi, Takeda Pharmaceutical

What are the Application segmentation covered in the Dengue Fever Treatment - Market report?

Ans: The Applications covered in the Dengue Fever Treatment - Market report are Hospital, Homecare, Specialty Clinics, Others

What are the Type segmentation covered in the Dengue Fever Treatment - Market report?

Ans: The Types covered in the Dengue Fever Treatment - Market report are Drug, Vaccines

1 Market Overview
1.1 Dengue Fever Treatment Product Introduction
1.2 Global Dengue Fever Treatment Market Size Forecast
1.2.1 Global Dengue Fever Treatment Sales Value (2019-2030)
1.2.2 Global Dengue Fever Treatment Sales Volume (2019-2030)
1.2.3 Global Dengue Fever Treatment Sales Price (2019-2030)
1.3 Dengue Fever Treatment Market Trends & Drivers
1.3.1 Dengue Fever Treatment Industry Trends
1.3.2 Dengue Fever Treatment Market Drivers & Opportunity
1.3.3 Dengue Fever Treatment Market Challenges
1.3.4 Dengue Fever Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Dengue Fever Treatment Players Revenue Ranking (2023)
2.2 Global Dengue Fever Treatment Revenue by Company (2019-2024)
2.3 Global Dengue Fever Treatment Players Sales Volume Ranking (2023)
2.4 Global Dengue Fever Treatment Sales Volume by Company Players (2019-2024)
2.5 Global Dengue Fever Treatment Average Price by Company (2019-2024)
2.6 Key Manufacturers Dengue Fever Treatment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Dengue Fever Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Dengue Fever Treatment
2.9 Dengue Fever Treatment Market Competitive Analysis
2.9.1 Dengue Fever Treatment Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Dengue Fever Treatment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Fever Treatment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Drug
3.1.2 Vaccines
3.2 Global Dengue Fever Treatment Sales Value by Type
3.2.1 Global Dengue Fever Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Dengue Fever Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Dengue Fever Treatment Sales Value, by Type (%) (2019-2030)
3.3 Global Dengue Fever Treatment Sales Volume by Type
3.3.1 Global Dengue Fever Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Dengue Fever Treatment Sales Volume, by Type (2019-2030)
3.3.3 Global Dengue Fever Treatment Sales Volume, by Type (%) (2019-2030)
3.4 Global Dengue Fever Treatment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Homecare
4.1.3 Specialty Clinics
4.1.4 Others
4.2 Global Dengue Fever Treatment Sales Value by Application
4.2.1 Global Dengue Fever Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Dengue Fever Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Dengue Fever Treatment Sales Value, by Application (%) (2019-2030)
4.3 Global Dengue Fever Treatment Sales Volume by Application
4.3.1 Global Dengue Fever Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Dengue Fever Treatment Sales Volume, by Application (2019-2030)
4.3.3 Global Dengue Fever Treatment Sales Volume, by Application (%) (2019-2030)
4.4 Global Dengue Fever Treatment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Dengue Fever Treatment Sales Value by Region
5.1.1 Global Dengue Fever Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Dengue Fever Treatment Sales Value by Region (2019-2024)
5.1.3 Global Dengue Fever Treatment Sales Value by Region (2025-2030)
5.1.4 Global Dengue Fever Treatment Sales Value by Region (%), (2019-2030)
5.2 Global Dengue Fever Treatment Sales Volume by Region
5.2.1 Global Dengue Fever Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Dengue Fever Treatment Sales Volume by Region (2019-2024)
5.2.3 Global Dengue Fever Treatment Sales Volume by Region (2025-2030)
5.2.4 Global Dengue Fever Treatment Sales Volume by Region (%), (2019-2030)
5.3 Global Dengue Fever Treatment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Dengue Fever Treatment Sales Value, 2019-2030
5.4.2 North America Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Dengue Fever Treatment Sales Value, 2019-2030
5.5.2 Europe Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Dengue Fever Treatment Sales Value, 2019-2030
5.6.2 Asia Pacific Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Dengue Fever Treatment Sales Value, 2019-2030
5.7.2 South America Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Dengue Fever Treatment Sales Value, 2019-2030
5.8.2 Middle East & Africa Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Dengue Fever Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Dengue Fever Treatment Sales Value
6.2.1 Key Countries/Regions Dengue Fever Treatment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Dengue Fever Treatment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Dengue Fever Treatment Sales Value, 2019-2030
6.3.2 United States Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Dengue Fever Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Dengue Fever Treatment Sales Value, 2019-2030
6.4.2 Europe Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Dengue Fever Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Dengue Fever Treatment Sales Value, 2019-2030
6.5.2 China Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Dengue Fever Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Dengue Fever Treatment Sales Value, 2019-2030
6.6.2 Japan Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Dengue Fever Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Dengue Fever Treatment Sales Value, 2019-2030
6.7.2 South Korea Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Dengue Fever Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Dengue Fever Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Dengue Fever Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Dengue Fever Treatment Sales Value, 2019-2030
6.9.2 India Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Dengue Fever Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Fresenius Kabi USA
7.1.1 Fresenius Kabi USA Company Information
7.1.2 Fresenius Kabi USA Introduction and Business Overview
7.1.3 Fresenius Kabi USA Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Fresenius Kabi USA Dengue Fever Treatment Product Offerings
7.1.5 Fresenius Kabi USA Recent Development
7.2 Sun Pharmaceutical Industries
7.2.1 Sun Pharmaceutical Industries Company Information
7.2.2 Sun Pharmaceutical Industries Introduction and Business Overview
7.2.3 Sun Pharmaceutical Industries Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sun Pharmaceutical Industries Dengue Fever Treatment Product Offerings
7.2.5 Sun Pharmaceutical Industries Recent Development
7.3 Mylan N.V
7.3.1 Mylan N.V Company Information
7.3.2 Mylan N.V Introduction and Business Overview
7.3.3 Mylan N.V Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Mylan N.V Dengue Fever Treatment Product Offerings
7.3.5 Mylan N.V Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Dengue Fever Treatment Product Offerings
7.4.5 Pfizer Recent Development
7.5 Teva Pharmaceuticals USA
7.5.1 Teva Pharmaceuticals USA Company Information
7.5.2 Teva Pharmaceuticals USA Introduction and Business Overview
7.5.3 Teva Pharmaceuticals USA Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Teva Pharmaceuticals USA Dengue Fever Treatment Product Offerings
7.5.5 Teva Pharmaceuticals USA Recent Development
7.6 EMERGEX VACCINES
7.6.1 EMERGEX VACCINES Company Information
7.6.2 EMERGEX VACCINES Introduction and Business Overview
7.6.3 EMERGEX VACCINES Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 EMERGEX VACCINES Dengue Fever Treatment Product Offerings
7.6.5 EMERGEX VACCINES Recent Development
7.7 Hikma Pharmaceuticals
7.7.1 Hikma Pharmaceuticals Company Information
7.7.2 Hikma Pharmaceuticals Introduction and Business Overview
7.7.3 Hikma Pharmaceuticals Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Hikma Pharmaceuticals Dengue Fever Treatment Product Offerings
7.7.5 Hikma Pharmaceuticals Recent Development
7.8 ABIVAX, Aurobindo Pharma
7.8.1 ABIVAX, Aurobindo Pharma Company Information
7.8.2 ABIVAX, Aurobindo Pharma Introduction and Business Overview
7.8.3 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Product Offerings
7.8.5 ABIVAX, Aurobindo Pharma Recent Development
7.9 Baxter
7.9.1 Baxter Company Information
7.9.2 Baxter Introduction and Business Overview
7.9.3 Baxter Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Baxter Dengue Fever Treatment Product Offerings
7.9.5 Baxter Recent Development
7.10 Perrigo
7.10.1 Perrigo Company Information
7.10.2 Perrigo Introduction and Business Overview
7.10.3 Perrigo Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Perrigo Dengue Fever Treatment Product Offerings
7.10.5 Perrigo Recent Development
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Information
7.11.2 GlaxoSmithKline Introduction and Business Overview
7.11.3 GlaxoSmithKline Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.11.4 GlaxoSmithKline Dengue Fever Treatment Product Offerings
7.11.5 GlaxoSmithKline Recent Development
7.12 Dr. Reddy’s Laboratories
7.12.1 Dr. Reddy’s Laboratories Company Information
7.12.2 Dr. Reddy’s Laboratories Introduction and Business Overview
7.12.3 Dr. Reddy’s Laboratories Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Dr. Reddy’s Laboratories Dengue Fever Treatment Product Offerings
7.12.5 Dr. Reddy’s Laboratories Recent Development
7.13 Sanofi
7.13.1 Sanofi Company Information
7.13.2 Sanofi Introduction and Business Overview
7.13.3 Sanofi Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Sanofi Dengue Fever Treatment Product Offerings
7.13.5 Sanofi Recent Development
7.14 Takeda Pharmaceutical
7.14.1 Takeda Pharmaceutical Company Information
7.14.2 Takeda Pharmaceutical Introduction and Business Overview
7.14.3 Takeda Pharmaceutical Dengue Fever Treatment Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Takeda Pharmaceutical Dengue Fever Treatment Product Offerings
7.14.5 Takeda Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Dengue Fever Treatment Industrial Chain
8.2 Dengue Fever Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Dengue Fever Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Dengue Fever Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Dengue Fever Treatment Market Trends
    Table 2. Dengue Fever Treatment Market Drivers & Opportunity
    Table 3. Dengue Fever Treatment Market Challenges
    Table 4. Dengue Fever Treatment Market Restraints
    Table 5. Global Dengue Fever Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Dengue Fever Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Global Dengue Fever Treatment Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Dengue Fever Treatment Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Dengue Fever Treatment Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Dengue Fever Treatment Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Dengue Fever Treatment Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Dengue Fever Treatment
    Table 13. Global Dengue Fever Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dengue Fever Treatment as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dengue Fever Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Dengue Fever Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Dengue Fever Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Dengue Fever Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Dengue Fever Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Dengue Fever Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Dengue Fever Treatment Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Dengue Fever Treatment Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Dengue Fever Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Dengue Fever Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Dengue Fever Treatment Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Dengue Fever Treatment Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Dengue Fever Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Dengue Fever Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Dengue Fever Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Dengue Fever Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Dengue Fever Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Dengue Fever Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Dengue Fever Treatment Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Dengue Fever Treatment Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Dengue Fever Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Dengue Fever Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Dengue Fever Treatment Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Dengue Fever Treatment Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Dengue Fever Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Dengue Fever Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Dengue Fever Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Dengue Fever Treatment Sales Value by Region (2019-2024) & (%)
    Table 44. Global Dengue Fever Treatment Sales Value by Region (2025-2030) & (%)
    Table 45. Global Dengue Fever Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Dengue Fever Treatment Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Dengue Fever Treatment Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Dengue Fever Treatment Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Dengue Fever Treatment Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Dengue Fever Treatment Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Dengue Fever Treatment Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Dengue Fever Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Dengue Fever Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Dengue Fever Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Dengue Fever Treatment Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Dengue Fever Treatment Sales Volume, (2025-2030) & (K Units)
    Table 57. Fresenius Kabi USA Company Information
    Table 58. Fresenius Kabi USA Introduction and Business Overview
    Table 59. Fresenius Kabi USA Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Fresenius Kabi USA Dengue Fever Treatment Product Offerings
    Table 61. Fresenius Kabi USA Recent Development
    Table 62. Sun Pharmaceutical Industries Company Information
    Table 63. Sun Pharmaceutical Industries Introduction and Business Overview
    Table 64. Sun Pharmaceutical Industries Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Sun Pharmaceutical Industries Dengue Fever Treatment Product Offerings
    Table 66. Sun Pharmaceutical Industries Recent Development
    Table 67. Mylan N.V Company Information
    Table 68. Mylan N.V Introduction and Business Overview
    Table 69. Mylan N.V Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Mylan N.V Dengue Fever Treatment Product Offerings
    Table 71. Mylan N.V Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Pfizer Dengue Fever Treatment Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Teva Pharmaceuticals USA Company Information
    Table 78. Teva Pharmaceuticals USA Introduction and Business Overview
    Table 79. Teva Pharmaceuticals USA Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Teva Pharmaceuticals USA Dengue Fever Treatment Product Offerings
    Table 81. Teva Pharmaceuticals USA Recent Development
    Table 82. EMERGEX VACCINES Company Information
    Table 83. EMERGEX VACCINES Introduction and Business Overview
    Table 84. EMERGEX VACCINES Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. EMERGEX VACCINES Dengue Fever Treatment Product Offerings
    Table 86. EMERGEX VACCINES Recent Development
    Table 87. Hikma Pharmaceuticals Company Information
    Table 88. Hikma Pharmaceuticals Introduction and Business Overview
    Table 89. Hikma Pharmaceuticals Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Hikma Pharmaceuticals Dengue Fever Treatment Product Offerings
    Table 91. Hikma Pharmaceuticals Recent Development
    Table 92. ABIVAX, Aurobindo Pharma Company Information
    Table 93. ABIVAX, Aurobindo Pharma Introduction and Business Overview
    Table 94. ABIVAX, Aurobindo Pharma Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. ABIVAX, Aurobindo Pharma Dengue Fever Treatment Product Offerings
    Table 96. ABIVAX, Aurobindo Pharma Recent Development
    Table 97. Baxter Company Information
    Table 98. Baxter Introduction and Business Overview
    Table 99. Baxter Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Baxter Dengue Fever Treatment Product Offerings
    Table 101. Baxter Recent Development
    Table 102. Perrigo Company Information
    Table 103. Perrigo Introduction and Business Overview
    Table 104. Perrigo Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Perrigo Dengue Fever Treatment Product Offerings
    Table 106. Perrigo Recent Development
    Table 107. GlaxoSmithKline Company Information
    Table 108. GlaxoSmithKline Introduction and Business Overview
    Table 109. GlaxoSmithKline Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. GlaxoSmithKline Dengue Fever Treatment Product Offerings
    Table 111. GlaxoSmithKline Recent Development
    Table 112. Dr. Reddy’s Laboratories Company Information
    Table 113. Dr. Reddy’s Laboratories Introduction and Business Overview
    Table 114. Dr. Reddy’s Laboratories Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Dr. Reddy’s Laboratories Dengue Fever Treatment Product Offerings
    Table 116. Dr. Reddy’s Laboratories Recent Development
    Table 117. Sanofi Company Information
    Table 118. Sanofi Introduction and Business Overview
    Table 119. Sanofi Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Sanofi Dengue Fever Treatment Product Offerings
    Table 121. Sanofi Recent Development
    Table 122. Takeda Pharmaceutical Company Information
    Table 123. Takeda Pharmaceutical Introduction and Business Overview
    Table 124. Takeda Pharmaceutical Dengue Fever Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Takeda Pharmaceutical Dengue Fever Treatment Product Offerings
    Table 126. Takeda Pharmaceutical Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Dengue Fever Treatment Downstream Customers
    Table 130. Dengue Fever Treatment Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dengue Fever Treatment Product Picture
    Figure 2. Global Dengue Fever Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dengue Fever Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Dengue Fever Treatment Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Dengue Fever Treatment Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Dengue Fever Treatment Report Years Considered
    Figure 7. Global Dengue Fever Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Dengue Fever Treatment Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Dengue Fever Treatment Revenue in 2023
    Figure 10. Dengue Fever Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Drug Picture
    Figure 12. Vaccines Picture
    Figure 13. Global Dengue Fever Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Dengue Fever Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Dengue Fever Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Dengue Fever Treatment Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Dengue Fever Treatment Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Homecare
    Figure 20. Product Picture of Specialty Clinics
    Figure 21. Product Picture of Others
    Figure 22. Global Dengue Fever Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Dengue Fever Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Dengue Fever Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Dengue Fever Treatment Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Dengue Fever Treatment Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Dengue Fever Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Dengue Fever Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Dengue Fever Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Dengue Fever Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Dengue Fever Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Dengue Fever Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Dengue Fever Treatment Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Dengue Fever Treatment Sales Volume (%), (2019-2030)
    Figure 39. United States Dengue Fever Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Dengue Fever Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Dengue Fever Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Dengue Fever Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Dengue Fever Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Dengue Fever Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Dengue Fever Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Dengue Fever Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Dengue Fever Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Dengue Fever Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Dengue Fever Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Dengue Fever Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Dengue Fever Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Dengue Fever Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Dengue Fever Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 60. Dengue Fever Treatment Industrial Chain
    Figure 61. Dengue Fever Treatment Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Add to Cart

Meningococcal Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37Q13661
Wed Nov 06 00:00:00 UTC 2024

Add to Cart